Drug therapy of bacillus Calmette-Gu�rin sepsis

✍ Scribed by Koukol, S. C. ;DeHaven, J. I. ;Riggs, D. R. ;Lamm, D. L.

• Book ID: 104710652
• Publisher: Springer
• Year: 1995
• Tongue: English
• Weight: 363 KB
• Volume: 22
• Category: Article
• ISSN: 0300-5623
• DOI: 10.1007/bf00296878

✦ Synopsis

Intravesical bacillus Calmette-Guérin (BCG) is widely used for the treatment of transitional cell carcinoma of the bladder. Although it is usually well tolerated, sepsis can occur, which has resulted in at least eight deaths [3]. The survival of Connaught BCG-infected mice treated with single and combination antibiotic and steroid therapy was evaluated. Triple-drug therapy with isoniazid, rifampin, and prednisolone resulted in 53% survival compared with 25% survival in the control group (P = 0.0209). A survival of only 10.5% was observed with treatment using prednisolone alone. This survival was worse than that of the control group (25%), and approached statistical significance (P = 0.0669). Our data suggest that BCG sepsis probably has components of both a hypersensitivity reaction and bacterial sepsis; they support the current use of combination antibiotic and steroid therapy for treatment of BCG sepsis in humans, but argue against treatment with steroids alone.